Stock VBIV VBI VACCINES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus VBI Vaccines Inc.

Equities

VBIV

CA91822J2020

Market Closed - Nasdaq
Other stock markets
 01:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
0.564 USD -1.74% Intraday chart for VBI Vaccines Inc. -6.47% -4.00%
16/04 VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
15/04 North American Morning Briefing : Stock Futures -2- DJ

Evolution of the average Target Price on VBI Vaccines Inc.

Price target over the last 5 years

History of analyst recommendation changes

70151569683e949f018.8rqLh4MzmdfSJUT99DHfUO-fX4igs8Q0e6IxIn1tTdE.peLvyvRA0ZK1aDW5w0eNBbf7CsDCw_VEMZJDeBc_OrLD1u_d11T_5edwLw~ed4722696b36101e51429cf8efa88dd0

Analyst Recommendations on VBI Vaccines Inc.

Raymond James Cuts Price Target on VBI Vaccines to $6 From $60, Maintains Outperform Rating MT
Raymond James Adjusts VBI Vaccines Price Target to $6 From $9, Maintains Strong Buy Rating MT
Jefferies Analyst Starts VBI Vaccines at Buy, Adjusts Price Target to $6 From $7 MT
VBI VACCINES : Jefferies Starts VBI Vaccines at Buy With $7 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.564 USD
Average target price
5 USD
Spread / Average Target
+786.52%
High Price Target
5 USD
Spread / Highest target
+786.52%
Low Price Target
5 USD
Spread / Lowest Target
+786.52%

Consensus detail

Consensus revision (last 18 months)

Analysts covering VBI Vaccines Inc.

Raymond James
Jefferies & Co.

Ratings for VBI Vaccines Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. VBIV Stock
  4. Consensus VBI Vaccines Inc.